ENTRY       D09670                      Drug
NAME        Sotatercept (USAN/INN)
FORMULA     C3448H5264N920O1058S42
EXACT_MASS  77829.4657
MOL_WEIGHT  77878.949
SEQUENCE    ILGRSETQEC LFFNANWEKD RTNQTGVEPC YGDKDKRRHC FATWKNISGS IEIVKQGCWL
            DDINCYDRTD CVEKKDSPEV YFCCCEGNMC NEKFSYFPEM EVTQPTSNPV TPKPPTGGGT
            HTCPPCPAPE LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE
            VHNAKTKPRE EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPVPIE KTISKAKGQP
            REPQVYTLPP SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS
            FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGK
            (Disulfide bridge: 10-40, 30-58, 65-84, 71-83, 85-90, 158-218, 264-322, 123-123', 126-126')
  TYPE      Peptide
EFFICACY    Anti-anemic, Bone anabolic
COMMENT     Fusion protein (extracellular domain of the activin receptor 2A and Fc of IgG1)
            Red cell maturation agent for the treatment of anemia, and bone anabolic agent for the treatment of cancer-related bone loss
TARGET      ACVR2A [HSA:92] [KO:K04670]
  PATHWAY   hsa04060(92)  Cytokine-cytokine receptor interaction
            hsa04350(92)  TGF-beta signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor serine/threonine kinases (RSTK)
               TGFBR2 family
                ACVR2A
                 D09670  Sotatercept (USAN/INN)
DBLINKS     CAS: 1001080-50-7
            PubChem: 124490410
///
